机译:在日本受试者中采用新型测定方法测定的血清抗酒石酸酸性磷酸酶5b型活性的参考间隔
Department of Metabolism Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine 1-4-3 Asahi-machi Abeno-ku Osaka 545-8585 Japan;
Department of Metabolism Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine 1-4-3 Asahi-machi Abeno-ku Osaka 545-8585 Japan;
Yoro Orthopedic Clinic Gifu Japan;
Yamashita Clinic Fukuoka Japan;
Department of Geriatric Medicine Osaka City University Graduate School of Medicine Osaka Japan;
Department of Metabolism Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine 1-4-3 Asahi-machi Abeno-ku Osaka 545-8585 Japan;
Department of Metabolism Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine 1-4-3 Asahi-machi Abeno-ku Osaka 545-8585 Japan;
Department of Obstetrics and Gynecology Yokohama City University School of Medicine Kanagawa Japan;
Department of Obstetrics and Gynecology Yokohama City University School of Medicine Kanagawa Japan;
Department of Obstetrics and Gynecology Dokkyo University School of Medicine Tochigi Japan;
tartrate-resistant acid phosphatase 5b (TRACP-5b); osteoclastic activity; fragments absorbed immunocapture enzymatic assay (FAICEA); reference interval;
机译:在日本受试者中使用新型检测方法测定的血清抗酒石酸酸性磷酸酶5b型活性的参考间隔。
机译:血清中抗5t酒石酸酸性磷酸酶活性的动力学测定方法的建立
机译:血清中两种骨衍生酶活性的参考区间:碱性磷酸酶(ALP)和抗酒石酸酸性磷酸酶(TR-ACP)的骨同工酶。
机译:C末端端肽和抗酒石酸酸性磷酸酶作为骨吸收的标志
机译:抗酒石酸酸性磷酸酶:大肠癌的预后和M1 / M2的区别。
机译:血清抗酒石酸酸性磷酸酶5b活性作为乳腺癌骨转移生存的预后指标
机译:albers-schonberg病(II型常染色体显性遗传性骨硬化症)中破骨细胞来源的酒石酸抗性酸性磷酸酶5b